Recothrom 20,000 UN 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FASQR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,784
Award facts
- Contract value 100% obligated
- $18,783.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $18,783.90 firm fixed price delivery order for 20,000 units of RECOTHROM, a thrombin-based hemostatic agent used in surgical settings to control bleeding. This non-set-aside competitive award was issued on December 11, 2025, with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical supply requirements through competitive procurement processes. This delivery order for RECOTHROM represents one of numerous pharmaceutical and medical supply transactions the contractor executes under its DLA prime vendor agreement to support Defense Health Agency and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FASQR?
SPE2DR26FASQR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FASQR worth?
The government has obligated $18,784 on SPE2DR26FASQR.
Is contract SPE2DR26FASQR an order under another contract?
Yes. SPE2DR26FASQR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FASQR competed?
The extent of competition for SPE2DR26FASQR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award